SCHEMBL5222819

SCHEMBL5222819

OCCCON1CCCCC1

nearest known ligand 0.32

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.32
SLC29A1 Q99808 1/20 0.31
MEN1 O00255 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28630734 0.82
SCHEMBL28657416 0.77
SCHEMBL11730807 0.77
SCHEMBL5222817 0.76
SCHEMBL28724717 0.76
SCHEMBL3127470 0.76 TSHR (0.42) HRH3MEN1CYP3A4CYP2C9KMT2A
SCHEMBL528149 0.74 LTA4H (0.41) MEN1KMT2A
SCHEMBL3170042 0.74 ALDH1A1 (0.33) SLC29A1
SCHEMBL2264282 0.74 MGLL (0.31) MEN1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL16411840 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1827434-A2 QUINOLINES AND QUINAZOLINE ANALOGS AND THEIR USE AS MEDICAMENTS FOR TREATING CANCER Amgen Inc. (US) 2007-09-05 EP claimed
WO-2006060318-A2 QUINOLINES AND QUINAZOLINE ANALOGS AND THEIR USE AS MEDICAMENTS FOR TREATING CANCER AMGEN INC. (US) 2006-06-08 WO claimed